Table 1.
Title | Test Agent | Biofilms | Results Summary | Reference |
---|---|---|---|---|
Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa | ES |
S. aureus
P. aeruginosa |
A quantity of 0.2 µg of ES abolished S. aureus biofilm formation: 8 h incubation. Degradation of P. aeruginosa biofilms > 10 h incubation; required 10-fold more ES than S. aureus biofilms. Boiling of ES abrogated their effects on S. aureus but not on P. aeruginosa biofilms. | [84] |
Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions | ES | S. epidermidis | In the presence of ES, S. epidermidis 1457 and 5179-R1 nascent biofilm formation was inhibited, and pre-formed biofilms were disrupted. ES activity was temperature- and time-dependent, inactivated by heat treatment, and disruption depended on the mechanism of intercellular adhesion. | [85] |
The Influence of Maggot Excretions on PAO1 Biofilm Formation on Different Biomaterials | ES | P. aeruginosa | Maggot ES prevents and inhibits PAO1 biofilm formation and degrades existing biofilms. ES still had considerable biofilm-reduction properties after storage at room temperature for 1 month. ES from instar-3 maggots were more effective than ES from instar-1 maggots. | [86] |
Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom | ES | S. aureus | A quantity of 20–200 mg/L ES eradicated S. aureus biofilms within 3 h. Enhanced antimicrobial activity of daptomycin against biofilms. | [87] |
Maggot excretions inhibit biofilm formation on biomaterials | ES |
S. aureus
S. epidermidis K. oxytoca E. faecalis E. cloacae |
The presence of excretions/secretions reduced biofilm formation on all biomaterials. A maximum of 92% of biofilm reduction was measured. | [88] |
Blow fly Lucilia sericata nuclease digests DNA associated with wound slough/eschar and with Pseudomonas aeruginosa biofilm | ES | P. aeruginosa | A quantity of 20 µg/mL ES resulted in an ~50% reduction in pre-formed biofilms. | [89] |
Excretions/secretions from bacteria-pretreated maggot are more effective against Pseudomonas aeruginosa biofilms | ES | P. aeruginosa | Researchers stated that ES obtained from larvae pre-treated with 1 × 106 CFU/mL P. aeruginosa displayed enhanced inhibition of nascent biofilm formation. | [90] |
Lucilia sericata chymotrypsin disrupts protein adhesin-mediated staphylococcal biofilm formation | Recombinant larval derived enzyme |
S. aureus
S. epidermidis |
Chymotrypsin derived from maggot excretions/secretions disrupts protein-dependent bacterial biofilm-formation mechanisms. | [91] |
Chronic Wounds, Biofilms and Use of Medicinal Larvae | L. sericata larvae |
S. aureus
P. aeruginosa |
Biofilms of P. aeruginosa and S. aureus grown on dermal pig explants were eradicated (6-log reduction) following a 48-h application of live L. sericata larvae. Following 24 h exposure, a 5-log reduction was observed. | [92] |
Selective Antibiofilm Effects of Lucilia sericata Larvae Secretions/Excretions against Wound Pathogens | ES |
S. aureus
E. cloacae P. mirabilis |
Maggot ES at 100 mg/mL concentration significantly reduced biofilm formation and disrupted established biofilm of E. cloacae. Heat-treated ES did not show any antibiofilm activity towards E. cloacae. Similar results were obtained in the case of S. aureus; however, the heat-treatment of maggot ES did not affect its antibiofilm activity. | [93] |
Antibacterial and antibiofilm effects of fatty acids extract of dried Lucilia sericata larvae against Staphylococcus aureus and Streptococcus pneumoniae in vitro | Fatty acid extraction from dried and crushed L. sericata larvae |
S. aureus
S. pneumoniae |
The fatty acid extract successfully inhibited the formation of biofilm and degraded mature biofilm produced by both species tested. Antibiofilm effects were concentration dependent. | [94] |
Maggot Extract Interrupts Bacterial Biofilm Formation and Maturation in Combination with Antibiotics by Reducing the Expression of Virulence Genes | L. sericata extract |
S. aureus
P. aeruginosa |
Significant reduction in observed biofilms in ex vivo human-dermal-skin explant model for both bacteria treated. | [95] |